NasdaqGM - Delayed Quote USD

Beta Bionics, Inc. Common Stock (BBNX)

23.63

+6.63

+(39.00%)

At close: January 30 at 4:00:02 PM EST

Beta Bionics raises $204m to kickstart medtech IPO season

Already eclipsing many IPO values in 2024, Beta Bionics hits the Nasdaq boards with a healthy offering.

Medical Device Network 15 hours ago

BBNX
+39.00%
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common stock at a price to the public of $17.00 per share. The gross proceeds to Beta Bionics from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Beta Bionics, are expected to be $204.0 million. In add

GlobeNewswire yesterday

BBNX
+39.00%